Strength in numbers: antifungal strategies against fungal biofilms

Area of Science:

• Mycology
• Infectious Diseases
• Biomedical Engineering

Background:

• Pathogenic fungi create resilient biofilms that resist antifungal treatments.
• Fungal biofilms are widespread in humans, affecting various organs and medical implants.
• Candida albicans is a primary cause of hospital-acquired fungal infections due to its biofilm-forming capabilities.

Purpose of the Study:

• To review significant fungal biofilm-forming organisms and their clinical impact.
• To discuss current and emerging strategies for managing fungal biofilm infections.
• To synthesize findings from in vitro and in vivo studies on fungal biofilms.

Main Methods:

• Literature review of fungal biofilm research.
• Analysis of clinical significance of key fungal pathogens.
• Evaluation of existing and novel treatment strategies.

Main Results:

• Fungal biofilms present a major challenge in treating infections, particularly on medical devices.
• Candida albicans biofilms are linked to high mortality rates in nosocomial infections.
• Diverse fungal species contribute to biofilm-related pathologies across multiple human body sites.

Conclusions:

• Fungal biofilms are a critical clinical concern requiring effective management strategies.
• Novel therapeutic approaches are needed to overcome antifungal resistance in biofilms.
• Understanding fungal biofilm formation is key to developing better treatments.